Clinical Trial: Sublingual Misoprostol for the Treatment of Incomplete Abortion: Operations Research
Study Status: Not yet recruiting
Recruit Status: Not yet recruiting
Study Type: Interventional
Official Title: Sublingual Misoprostol for the Treatment of Incomplete Abortion: Operations Research
Brief Summary: This study will investigate the use of misoprostol for first-line treatment of incomplete abortion at tertiary hospitals in Myanmar.
Detailed Summary: This open-label feasibility study seeks to examine the potential of 400μg sublingual misoprostol for the treatment of incomplete abortion provided at tertiary hospitals.
Sponsor: Gynuity Health Projects
Current Primary Outcome: Percentage of women with complete uterine evacuation with study medication alone. [ Time Frame: 14 days ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- Percentage of women experiencing side effects [ Time Frame: 7-14 days ]occurrence of side effects, if any, including fever, chills, nausea, vomiting, headache, diarrhea, and pain.
- Level of self-reported acceptability of treatment [ Time Frame: 7-14 days ]Woman's satisfaction with the treatment, woman's likelihood to use the treatment in the future, woman's likelihood of recommending the treatment to a friend, providers' satisfaction with the treatment, likelihood provider would recommend the treatment in a similar situation.
Original Secondary Outcome: Same as current
Information By: Gynuity Health Projects
Dates:
Date Received: February 19, 2016
Date Started: March 2016
Date Completion: March 2017
Last Updated: March 8, 2016
Last Verified: March 2016
